MR Fingerprinting of Adult Brain Tumors: Initial Experience

MR fingerprinting is a technique in which pseudorandomized acquisition parameters are used to simultaneously quantify multiple tissue properties, including T1 and T2 relaxation times. The authors evaluated the ability of MR fingerprinting–derived T1 and T2 relaxometry to differentiate the 3 common types of intra-axial brain tumors (17 glioblastomas, 6 lower grade gliomas, and 8 metastases). Using these parameters, they explored the T1 and T2 properties of peritumoral white matter in various tumor types. Mean T2 values could differentiate solid tumor regions of lowergrade gliomas from metastases and the mean T1 of peritumoral white matter surrounding lowergrade gliomas differed from peritumoral white matter around glioblastomas. BACKGROUND AND PURPOSE: MR fingerprinting allows rapid simultaneous quantification of T1 and T2 relaxation times. This study assessed the utility of MR fingerprinting in differentiating common types of adult intra-axial brain tumors. MATERIALS AND METHODS: MR fingerprinting acquisition was performed in 31 patients with untreated intra-axial brain tumors: 17 glioblastomas, 6 World Health Organization grade II lower grade gliomas, and 8 metastases. T1, T2 of the solid tumor, immediate peritumoral white matter, and contralateral white matter were summarized within each ROI. Statistical comparisons on mean, SD, skewness, and kurtosis were performed by using the univariate Wilcoxon rank sum test across various tumor types. Bonferroni correction was used to correct for multiple-comparison testing. Multivariable logistic regression analysis was performed for discrimination between glioblastomas and metastases, and area under the receiver operator curve was calculated. RESULTS: Mean T2 values could differentiate solid tumor regions of lower grade gliomas from metastases (mean, 172 ± 53 ms, and 105 ± 27 ms, respectively; P = .004, significant after Bonferroni correction). The mean T1 of peritumoral white matter surrounding lower grade gliomas differed from peritumoral white matter around glioblastomas (mean, 1066 ± 218 ms, and 1578 ± 331 ms, respectively; P = .004, significant after Bonferroni correction). Logistic regression analysis revealed that the mean T2 of solid tumor offered the best separation between glioblastomas and metastases with an area under the curve of 0.86 (95% CI, 0.69–1.00; P < .0001). CONCLUSIONS: MR fingerprinting allows rapid simultaneous T1 and T2 measurement in brain tumors and surrounding tissues. MR fingerprinting–based relaxometry can identify quantitative differences between solid tumor regions of lower grade gliomas and metastases and between peritumoral regions of glioblastomas and lower grade gliomas.

[1]  M Komiyama,et al.  MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. , 1987, AJNR. American journal of neuroradiology.

[2]  Z. Song,et al.  Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics , 2013, Clinical Neurology and Neurosurgery.

[3]  C. Thomsen,et al.  Tissue Characterization of Intracranial Tumors by MR Imaging , 1991, Acta radiologica.

[4]  Z. Wu,et al.  In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. , 2004, Clinical radiology.

[5]  M. Schluchter,et al.  Simultaneous T1 and T2 Brain Relaxometry in Asymptomatic Volunteers Using Magnetic Resonance Fingerprinting , 2015, Tomography.

[6]  D. Cicchetti Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. , 1994 .

[7]  Ming Zhang,et al.  Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI , 2013, Clinical Neurology and Neurosurgery.

[8]  B A Kall,et al.  Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.

[9]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[10]  M. Griswold,et al.  Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom , 2017, Magnetic resonance in medicine.

[11]  Stephen J Sawiak,et al.  MR fingerprinting with simultaneous B1 estimation , 2015, Magnetic resonance in medicine.

[12]  G. Barger,et al.  Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates , 2013, Journal of Neuro-Oncology.

[13]  J. Hennig,et al.  Pseudo Steady‐State Free Precession for MR‐Fingerprinting , 2017, Magnetic resonance in medicine.

[14]  Albert Lai,et al.  Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab , 2011, Journal of Neuro-Oncology.

[15]  Lawrence L. Wald,et al.  Maximum likelihood reconstruction for magnetic resonance fingerprinting , 2016, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

[16]  J. Duerk,et al.  Magnetic Resonance Fingerprinting , 2013, Nature.

[17]  V. Haughton,et al.  T1, T2 and proton density measurements in the grading of cerebral gliomas , 2004, European Radiology.

[18]  Sean C L Deoni,et al.  Quantitative Relaxometry of the Brain , 2010, Topics in magnetic resonance imaging : TMRI.

[19]  Thomas Czech,et al.  Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  C. Zimmer,et al.  Multimodal imaging in cerebral gliomas and its neuropathological correlation. , 2014, European journal of radiology.

[21]  M. Griswold,et al.  MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout , 2015, Magnetic resonance in medicine.

[22]  Yong Chen,et al.  MR Fingerprinting for Rapid Quantitative Abdominal Imaging. , 2016, Radiology.

[23]  K. Swanson,et al.  Correlation of in vitro infiltration with glioma histological type in organotypic brain slices , 2004, British Journal of Cancer.

[24]  R. Deichmann,et al.  Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI , 2014, Neuroradiology.

[25]  R. Lober,et al.  The incidence and significance of multiple lesions in glioblastoma , 2013, Journal of Neuro-Oncology.

[26]  R. Damadian Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.

[27]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[28]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[29]  J. Henson,et al.  Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.

[30]  Siegfried Trattnig,et al.  Magnetic Resonance Fingerprinting - a promising new approach to obtain standardized imaging biomarkers from MRI , 2015, Insights into Imaging.

[31]  P. Kehrli,et al.  [Epidemiology of brain metastases]. , 1999, Neuro-Chirurgie.

[32]  Jill S. Barnholtz-Sloan,et al.  Epidemiologic and Molecular Prognostic Review of Glioblastoma , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[33]  T. Cloughesy,et al.  Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI , 2015, Clinical Cancer Research.

[34]  M. Berger,et al.  Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.

[35]  R. Tanaka,et al.  Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.

[36]  Alina Jurcoane,et al.  Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. , 2013, Neuro-oncology.

[37]  T. Carpenter,et al.  Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. , 2006, AJNR. American journal of neuroradiology.

[38]  Susan Chang,et al.  Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging , 2009, Current neurology and neuroscience reports.

[39]  J. Ironside,et al.  Diagnosis and pathogenesis of gliomas , 2007 .

[40]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Mark Muzi,et al.  Positron emission tomography imaging of brain tumors. , 2003, Neuroimaging clinics of North America.

[42]  J. Vymazal,et al.  Quantitative MR imaging and spectroscopy of brain tumours: a step forward? , 2012, European Radiology.

[43]  T. Goto,et al.  Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema , 2010, Journal of Neuro-Oncology.

[44]  Lutz Tellmann,et al.  Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. , 2009, Nuclear medicine and biology.

[45]  Jesse I. Hamilton,et al.  MR fingerprinting for rapid quantification of myocardial T1, T2, and proton spin density , 2017, Magnetic resonance in medicine.

[46]  Yi Yan,et al.  Quantitative analysis of glioma cell invasion by diffusion tensor imaging , 2010, Journal of Clinical Neuroscience.

[47]  T. Araki,et al.  Magnetic resonance imaging of brain tumors: measurement of T1. Work in progress. , 1984, Radiology.

[48]  M. Thelen,et al.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.

[49]  S. Filice,et al.  Lipid and Macromolecules Quantitation in Differentiating Glioblastoma From Solitary Metastasis: A Short–Echo Time Single-Voxel Magnetic Resonance Spectroscopy Study at 3 T , 2013, Journal of computer assisted tomography.

[50]  P. Desmond,et al.  Diffusion Tensor Imaging in Glioblastoma Multiforme and Brain Metastases: The Role of p, q, L, and Fractional Anisotropy , 2008, American Journal of Neuroradiology.

[51]  P. Brown,et al.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.

[52]  A. Chetrit,et al.  Original articles. , 2002, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[53]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.

[54]  N. Bulakbaşı,et al.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. , 2003, AJNR. American journal of neuroradiology.